Activation of p38 mitogen-activated protein kinase mediates thyroid hormone-stimulated osteocalcin synthesis in osteoblasts

Molecular and Cellular Endocrinology

Volumn 214, Issue 1-2, 2004, Pages 189-195

  Ishisaki, A ^a   Tokuda, H ^a,b   Yoshida, M ^a   Hirade, K ^a   Kunieda, K ^a   Hatakeyama, D ^a   Shibata, T ^a   Kozawa, O ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHUBU NATIONAL HOSPITAL   (Japan)

Author keywords

Mitogen activated protein kinase; Osteoblasts; Osteocalcin; Thyroid hormone

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELIN BASIC PROTEIN; OSTEOCALCIN; PROTEIN P44; THYROID HORMONE;

ANIMAL CELL; ARTICLE; CALVARIA; CELL CULTURE; DOSE RESPONSE; ENZYME ACTIVATION; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS;

EID: 1142297626     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.10.049     Document Type: Article

References (27)

1. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., Saltiel A.R. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
2. Boguslawski G., Hale L.V., Yu X.-P., Miles R.R., Onyia J.E., Santerre R.F., Chandraekhar S. Activation of osteocalcin transcription involves interaction of protein kinase A- and protein kinase C-dependent pathways. J. Biol. Chem. 275:2000;999-1006.
3. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229-233.
4. Daci E., Udagawa N., Martin T.J., Bouillon R., Carmeliet G. The role of the plasminogen system in bone resorption in vitro. J. Bone Miner. Res. 14:1999;946-952.
5. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
6. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase. J. Biol. Chem. 273:1998;18623-18632.
7. Huang B.K., Golden L.A., Tarjan G., Madison L.D., Stern P.H. Insulin-like growth factor I production is essential for anabolic effects of thyroid hormone in osteoblasts. J. Bone Miner. Res. 15:2000;188-197.
8. Kasono K., Sato K., Han D.C., Fujii Y., Tsushima T., Shizume K. Stimulatory effect of alkaline phosphatase activity by thyroid hormone in mouse osteoblast-like (MC3T3-E1): a possible mechanism of hyperalkaline phosphatasia in hyperthyroidism. Bone Miner. 4:1988;355-363.
9. Kato K., Ito H., Hasegawa K., Inaguma Y., Kozawa O., Asano T. Modulation of the stress-induced synthesis of hsp27 and αB-crystallin by cyclic AMP in C6 rat glioma cells. J. Neurochem. 66:1996;946-950.
10. Khosla, S., Melton III, L.J., 1995. Osteoporosis. In: Riggs, L.G., Melton III, L.J. (Eds.), Etiology, Diagnosis and Management, second ed. Lippincott-Raven Publishers, Philadelphia, pp. 183-204.
11. Kozawa O., Hatakeyama D., Yoshida M., Kamiya Y., Kondo C., Matsuno H., Uematsu T. Activation of p44/p42 mitogen-activated protein kinase limits triiodothyronine-stimulated alkaline phosphatase activity in osteoblasts. Biochem. Biophys. Res. Commun. 286:2001;1140-1143.
12. 2 in osteoblast-like cells. Exp. Cell Res. 198:1992;130-134.
13. 2 in human osteosarcoma cells line MG-63. Eur. J. Endocrinol. 138:1998;443-448.
14. Kummer J.L., Rao P.K., Heidenreich K.A. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 282:1997;20490-20494.
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
16. Lali F.V., Hunt A.E., Turner S.J., Foxwell B.M.J. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J. Biol. Chem. 275:2000;7395-7402.
17. Nijweide P.J., Burger E.H., Feyen J.H.M. Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol. Rev. 66:1986;855-886.
18. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., Davis R.J. Pro-inflammatory cytokines and environmrntal stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation of tyrosine and threonine. J. Biol. Chem. 270:1995;7420-7426.
19. Rizzoli R., Poser J., Burgi U. Nuclear thyroid hormone receptor in cultured bone cells. Metabolism. 35:1986;71-74.
20. Robinson, R.J., Doty, S.B., Cooper, R.R., 1973. Electron micrography of mammalian bone. In: Zipkin, I. (Ed.), Biological Mineralization. Academic Press, New York, pp. 257-296.
21. Shih A., Lin H.Y., Davis F.B., Davis P.J. Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry. 40:2001;2870-2878.
22. Stern, P.H., 1996. Thyroid hormone and bone. In: Bilezikian, J.P., Raisz, L.G., Rodan, G.A. (Eds.), Principles of Bone Biology. Academic Press, San Diego, pp.521-531.
23. Sudo H., Kodama H., Amagai Y., Yamamoto S., Kasai S. In vivo differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell. Biol. 96:1983;191-198.
24. Tokuda H., Kozawa O., Harada A., Isobe K., Uematsu T. Triiodothyronine modulates interleukin-6 synthesis in osteoblasts: inhibition in protein kinase A and C pathways. Endocrinology. 139:1998;1300-1305.
25. Tokuda H., Kozawa O., Uematsu T. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase. J. Bone Miner. Res. 15:2000;2371-2379.
26. Tokuda H., Hirade K., Wang X., Oiso Y., Kozawa O. Involvement of SAPK/ JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts. J. Endocrinol. 177:2003;101-107.
27. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79:1999;143-180.